Marie Bleakley

5.2k total citations · 1 hit paper
55 papers, 3.4k citations indexed

About

Marie Bleakley is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, Marie Bleakley has authored 55 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 27 papers in Immunology and 25 papers in Hematology. Recurrent topics in Marie Bleakley's work include CAR-T cell therapy research (32 papers), Hematopoietic Stem Cell Transplantation (20 papers) and Immunotherapy and Immune Responses (17 papers). Marie Bleakley is often cited by papers focused on CAR-T cell therapy research (32 papers), Hematopoietic Stem Cell Transplantation (20 papers) and Immunotherapy and Immune Responses (17 papers). Marie Bleakley collaborates with scholars based in United States, South Africa and Australia. Marie Bleakley's co-authors include Stanley R. Riddell, Cassian Yee, Yongqing Li, Michael C. Jensen, Corinne Summers, Colleen Annesley, Rebecca Gardner, Julie R. Park, Philip D. Greenberg and Christopher Brown and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Marie Bleakley

51 papers receiving 3.3k citations

Hit Papers

Intent-to-treat leukemia remission by CD19 CAR T cells of... 2017 2026 2020 2023 2017 250 500 750

Peers

Marie Bleakley
Sarah Nikiforow United States
Mikhail Roshal United States
Caridad Martinez United States
Gary D. Myers United States
Jon Arnason United States
Michel G.D. Kester Netherlands
M. Helen Huls United States
Sarah Nikiforow United States
Marie Bleakley
Citations per year, relative to Marie Bleakley Marie Bleakley (= 1×) peers Sarah Nikiforow

Countries citing papers authored by Marie Bleakley

Since Specialization
Citations

This map shows the geographic impact of Marie Bleakley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie Bleakley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie Bleakley more than expected).

Fields of papers citing papers by Marie Bleakley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie Bleakley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie Bleakley. The network helps show where Marie Bleakley may publish in the future.

Co-authorship network of co-authors of Marie Bleakley

This figure shows the co-authorship network connecting the top 25 collaborators of Marie Bleakley. A scholar is included among the top collaborators of Marie Bleakley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie Bleakley. Marie Bleakley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Biernacki, Melinda A., Kimberly A. Foster, Carrie Cummings, et al.. (2025). SF3B1K700E Neoantigen Is a CD8+ T-cell Target Shared across Human Myeloid Neoplasms. Cancer Immunology Research. 13(9). 1391–1404.
2.
Biernacki, Melinda A. & Marie Bleakley. (2024). Clinical trials, challenges, and changes in TCR-based therapeutics for hematologic malignancies. Expert Review of Hematology. 18(1). 21–31.
3.
Biernacki, Melinda A., Kimberly A. Foster, Carrie Cummings, et al.. (2023). Discovery of U2AF1 neoantigens in myeloid neoplasms. Journal for ImmunoTherapy of Cancer. 11(12). e007490–e007490. 12 indexed citations
4.
Othus, Megan, Brenda M. Sandmaier, Filippo Milano, et al.. (2022). Utility of the Treatment-Related Mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation. Leukemia. 36(6). 1563–1574. 8 indexed citations
5.
Summers, Corinne, Qian Wu, Colleen Annesley, et al.. (2021). Hematopoietic Cell Transplantation after CD19 Chimeric Antigen Receptor T Cell-Induced Acute Lymphoblastic Leukemia Remission Confers a Leukemia-Free Survival Advantage. Transplantation and Cellular Therapy. 28(1). 21–29. 44 indexed citations
6.
Chew, Guo-Liang, Marie Bleakley, Robert K. Bradley, et al.. (2021). Short H2A histone variants are expressed in cancer. Nature Communications. 12(1). 490–490. 33 indexed citations
7.
Biernacki, Melinda A. & Marie Bleakley. (2020). Neoantigens in Hematologic Malignancies. Frontiers in Immunology. 11. 121–121. 27 indexed citations
8.
Biernacki, Melinda A., Vipul Sheth, & Marie Bleakley. (2020). T cell optimization for graft-versus-leukemia responses. JCI Insight. 5(9). 26 indexed citations
9.
Biernacki, Melinda A., et al.. (2016). Identifying Leukemia-Specific Neoepitopes from Next-Generation Sequencing Data to Develop Targeted Immunotherapy for Pediatric Acute Myeloid Leukemiaig. Biology of Blood and Marrow Transplantation. 22(3). S19–S19. 1 indexed citations
11.
Bleakley, Marie, Shelly Heimfeld, Lori Jones, et al.. (2014). Engineering Human Peripheral Blood Stem Cell Grafts that Are Depleted of Naïve T Cells and Retain Functional Pathogen-Specific Memory T Cells. Biology of Blood and Marrow Transplantation. 20(5). 705–716. 72 indexed citations
12.
Bleakley, Marie, Aiko Sato‐Otsubo, Hiroki Torikai, et al.. (2012). HapMap SNP Scanner: an online program to mine SNPs responsible for cell phenotype. Tissue Antigens. 80(2). 119–125. 4 indexed citations
13.
Pollack, Seth M., Achim A. Jungbluth, Benjamin Hoch, et al.. (2012). NY‐ESO‐1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma. Cancer. 118(18). 4564–4570. 101 indexed citations
14.
Bleakley, Marie, Brith Otterud, Michael Hudecek, et al.. (2010). Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells. Blood. 115(23). 4923–4933. 79 indexed citations
15.
Nishida, Tetsuya, Michael Hudecek, Ana Kostić, et al.. (2009). Development of Tumor-Reactive T Cells After Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant for Chronic Lymphocytic Leukemia. Clinical Cancer Research. 15(14). 4759–4768. 31 indexed citations
16.
Li, Yongqing, Marie Bleakley, & Cassian Yee. (2005). IL-21 Influences the Frequency, Phenotype, and Affinity of the Antigen-Specific CD8 T Cell Response. The Journal of Immunology. 175(4). 2261–2269. 221 indexed citations
17.
Halliday, Catriona, Tania C. Sorrell, Greg James, et al.. (2005). Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia. British Journal of Haematology. 132(4). 478–486. 68 indexed citations
18.
Ljungman, Per, Patricia Ribaud, Matthias Eyrich, et al.. (2003). Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation. 31(6). 481–486. 189 indexed citations
19.
Bleakley, Marie, Loretta M. S. Lau, Peter J. Shaw, & Andrew Kaufman. (2002). Bone marrow transplantation for paediatric AML in first remission: a systematic review and meta-analysis. Bone Marrow Transplantation. 29(10). 843–852. 37 indexed citations
20.
Shaw, Peter J. & Marie Bleakley. (2000). Systemic inflammatory response syndrome associated with amifostine. Medical and Pediatric Oncology. 34(4). 309–310. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026